AR and prostate cancer: Our study investigated the role and mechanism of cir-ITCH in PCa and provided evidence indicating that cir-ITCH functions as tumor suppressor in prostate cancer cells via the Wnt/β-catenin and PI3K/AKT/mTOR pathways in an AR-independent manner.